C
DNA icon

Covestor’s Ginkgo Bioworks DNA Stock Holding History

Covestor’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
1
– – ﹤0.01% 2363
2025
Q4 		$0 Hold
1
– – ﹤0.01% 2351
2025
Q3 		$0 Hold
1
– – ﹤0.01% 2372
2025
Q2 		$0 Hold
1
– – ﹤0.01% 2314
2025
Q1 		$0 Hold
1
– – ﹤0.01% 2326
2024
Q4 		$0 Hold
1
– – ﹤0.01% 2327
2024
Q3 		$0 Sell
1
-1
-50% -$10 ﹤0.01% 2315
2024
Q2 		$0 Sell
2
-3
-60% -$90 ﹤0.01% 2329
2024
Q1 		$0 Buy
5
+1
+25% +$52 ﹤0.01% 2327
2023
Q4 		$0 Hold
4
– – ﹤0.01% 2240
2023
Q3 		$0 Sell
4
-2
-33% -$160 ﹤0.01% 2217
2023
Q2 		$0 Buy
6
+3
+100% +$178 ﹤0.01% 2226
2023
Q1 		$0 Hold
3
– – ﹤0.01% 2127
2022
Q4 		$0 Buy
3
+1
+50% +$92 ﹤0.01% 2162
2022
Q3 		$0 Buy
+2
New +$238 ﹤0.01% 2105

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covestor's DNA Position: Q1 2026 in Review

Covestor held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

Covestor first reported a position in DNA in Q3 2022 and has held it in 15 quarters since. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Covestor held 1 share of Ginkgo Bioworks worth $0 as of Q1 2026.
  • Covestor left its Ginkgo Bioworks share count unchanged in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2363 holding.
  • Covestor first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 15 quarters since.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.